Belhaven Biopharma is a clinical trial material scale-up and production, IND preparation and filing.
Belhaven Biopharma has raised $10.0M in total funding. The most recent round was Series A. The last funding was announced in August 2025.
Belhaven Biopharma's investors include North Carolina Biotechnology Center.
Belhaven Biopharma is headquartered in Raleigh, United States.
Belhaven Biopharma is a clinical trial material scale-up and production, IND preparation and filing.
Belhaven Biopharma is at the Series A stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Belhaven Biopharma — Funding & Investors." VCBacked, August 19, 2025, https://www.vcbacked.co/company/belhaven-biopharma. Accessed October 8, 2026.
VCBacked. (2025). Belhaven Biopharma — Funding & Investors. Retrieved October 8, 2026, from https://www.vcbacked.co/company/belhaven-biopharma
{{cite web |title=Belhaven Biopharma — Funding & Investors |url=https://www.vcbacked.co/company/belhaven-biopharma |website=VCBacked |access-date=October 8, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated